SINGAPORE AIRLINES READY FOR CHALLENGE OF TRANSPORTING COVID-19 VACCINES GLOBALLY

 SINGAPORE AIRLINES READY FOR CHALLENGE OF 

TRANSPORTING COVID-19 VACCINES GLOBALLY

 

Mumbai, 05 December 2020 : Amid rapid developments in the testing and production of Covid-19 vaccines globally, Singapore Airlines (SIA) has made preparations to meet one of the largest and most important logistical challenges in recent history the safe and effective distribution of these vaccines around the world Over the last few months, SIA has been actively engaging various stakeholders across the supply chain and in pharmaceutical export markets to ensure that it is well-positioned to transport the vaccines with speed and reliability.

 An internal Covid-19 task force was set up in May 2020 to ensure readiness across all aspects of the Company’s cargo operations, and manage the crucial task of safely carrying these time- and temperature-sensitive pharmaceutical shipments

 Leveraging our network connectivity

 For the financial year ended March 2020, SIA Cargo carried about 22,000 tonnes of pharmaceutical shipments across its network. Singapore’s geographical location, coupled with SIA extensive network connectivity and the strong pharmaceutical handling capabilities at Singapore Changi Airport, positions it well as a key transit hub for the transportation and distribution of pharmaceuticals. It plays a key part in the air transportation of pharmaceuticals, particularly biologic shipments, from Europe and India to South East Asia, Australia and New Zealand.

 In order to strengthen its pharmaceutical transport product, SIA has been actively expanding its THRUCOOL1 quality corridor network, with the latest additions to the

1 SIA Cargo launched THRUCOOL in September 2018 as a cold chain service to transport high-value, timesensitive and temperature-controlled pharmaceutical cargo with speed and reliability. The service includes priority uplift and handling, quick ramp transfers at airports, cold room facilities, as well as thermal blankets and covers for crucial insulation from external factors.

Comments

Popular posts from this blog

Indegene acquires Trilogy Writing & Consulting GmbH, a medical writing consultancy

TiEcon Mumbai 2023, brilliantly showcased revolutionary ideas & impactful solutions to build an Anti-Fragile and Sustainable India

REC DECLARES ITS FINANCIAL RESULTS FOR Q2 & H1 FY24